rdf:type |
|
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0017262,
umls-concept:C0032064,
umls-concept:C0036126,
umls-concept:C0043408,
umls-concept:C0185117,
umls-concept:C0205148,
umls-concept:C0205151,
umls-concept:C0205263,
umls-concept:C0441889,
umls-concept:C0596988,
umls-concept:C1545588,
umls-concept:C2911684
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-5-15
|
pubmed:abstractText |
The caf operon from Yersinia pestis encoding the structural subunit (caf1), the molecular chaperone (caf1M), the outer membrane anchor (caf1A), and the regulatory protein (caf1R) was cloned into Salmonella typhimurium SL3261 aroA. The recombinant Salmonella organisms were encapsulated when cultured at 37 degrees C but not when cultured at 28 degrees C. Oral inoculation of mice with the recombinant Salmonella induced predominantly an immunoglobulin G2a response to F1 antigen, and isolated T cells showed a recall response to soluble or Salmonella-associated F1 antigen. Mice immunized with S. typhimurium SL3261 aroA expressing F1 antigen intracellularly developed lower antibody responses to F1 antigen and showed a T-cell recall response only to Salmonella-associated F1 antigen. Mice immunized orally with two doses of the recombinant Salmonella which expressed F1 antigen on the surface were protected against 10(7) 50% lethal doses (LD50) of virulent Y. pestis given by the subcutaneous route of challenge, whereas mice immunized with the recombinant Salmonella expressing F1 antigen intracellularly were only partially protected against 10(5) LD50 of Y. pestis.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-13342354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-13513584,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-1366519,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-1498769,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-1551441,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-1633857,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-1677900,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-1702734,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-2101478,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-2240367,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-2523712,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-3257252,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-3492308,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-4559742,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-4596517,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-4825248,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-4988692,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-6290337,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-7730666,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-7822022,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-7866091,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-8260457,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-8262559,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-8578807,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-8578841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-8643654,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-8675324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9125581-8745007
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0019-9567
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1926-30
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9125581-3-Phosphoshikimate 1-Carboxyvinyltransferase,
pubmed-meshheading:9125581-Administration, Oral,
pubmed-meshheading:9125581-Alkyl and Aryl Transferases,
pubmed-meshheading:9125581-Animals,
pubmed-meshheading:9125581-Bacterial Proteins,
pubmed-meshheading:9125581-Blotting, Western,
pubmed-meshheading:9125581-Colony Count, Microbial,
pubmed-meshheading:9125581-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:9125581-Female,
pubmed-meshheading:9125581-Fluorescent Antibody Technique, Indirect,
pubmed-meshheading:9125581-Gene Expression Regulation, Bacterial,
pubmed-meshheading:9125581-Immunoglobulin G,
pubmed-meshheading:9125581-Immunologic Memory,
pubmed-meshheading:9125581-Mice,
pubmed-meshheading:9125581-Mice, Inbred BALB C,
pubmed-meshheading:9125581-Microscopy, Phase-Contrast,
pubmed-meshheading:9125581-Operon,
pubmed-meshheading:9125581-Plague,
pubmed-meshheading:9125581-Plasmids,
pubmed-meshheading:9125581-Polymerase Chain Reaction,
pubmed-meshheading:9125581-Recombination, Genetic,
pubmed-meshheading:9125581-Salmonella Infections, Animal,
pubmed-meshheading:9125581-Salmonella typhimurium,
pubmed-meshheading:9125581-Spleen,
pubmed-meshheading:9125581-T-Lymphocytes,
pubmed-meshheading:9125581-Transferases,
pubmed-meshheading:9125581-Vaccination,
pubmed-meshheading:9125581-Vaccines, Synthetic,
pubmed-meshheading:9125581-Yersinia pestis
|
pubmed:year |
1997
|
pubmed:articleTitle |
Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.
|
pubmed:affiliation |
Defence Evaluation and Research Agency, Salisbury, Wiltshire, United Kingdom.
|